Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Dipyridamole may increase the effectiveness of methotrexate and
kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining methotrexate and dipyridamole
in treating patients with advanced ovarian cancer that is recurrent after or refractory to
cisplatin-based chemotherapy.